Axsome Therapeutics (AXSM) Stock Price
$137.8 0%
to add to portfolio
AI Score
-
Alternative
10 -
Fundamental
7 -
Technical
7
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Axsome Therapeutics, AI stock picks, stock alerts and much more.
AXSM AI Stock Analysis
Financial Performance
Axsome Therapeutics has shown impressive financial performance with a strong revenue growth of 46.5% YoY and an increase in gross profit by 50.2% YoY. Despite the operating income showing a loss, it's worth noting that it has improved by 36.2% YoY which indicates the company is moving towards profitability. The EBITDA ratio being -0.58 also signifies the company is not yet profitable.
Stock Price
The stock price has been performing well with a significant increase of 17.4% YoY and an impressive rise of 14.6% in just the last month alone. The RSI value at 68.12 suggests that the stock is nearing overbought territory, indicating investor enthusiasm for Axsome Therapeutics' shares while its PE ratio at -16.33 indicates investors are paying for each dollar of loss made by the firm.
Alternative Data Signals
The alternative data signals show positive trends as well; website traffic has increased by a solid rate both MoM (7.1%) and YoY (16.1%). This could indicate growing interest in the company or its products/services from customers or investors alike.The number of job openings have more than doubled MoM, suggesting aggressive expansion plans which can be seen as a positive signal for future growth potential.
The business outlook remains stable with no changes reported from previous month but shows high positivity among employees at around 79%. A growing social media presence on Twitter also suggests increasing recognition and popularity of Axsome Therapeutics.
Conclusion
In conclusion, despite some concerns about profitability reflected in negative EBITDA ratio and PE ratio, Axsome Therapeutics exhibits strong growth potential with impressive revenue and gross profit growth, positive stock price trends, and promising alternative data signals. Therefore, the AI stock analysis is cautiously bullish.
Note: This AI Stock Analysis is based on data as of February 04. Our members can refresh and get access to an up-to-date AI stock analysis.
Sign up
Axsome Therapeutics (AXSM) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Axsome Therapeutics (AXSM), currently trading at $137.8, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About AXSM
-
Axsome Therapeutics, Inc.
-
Symbol
AXSM
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
6.7B
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$21.62 2% |
6 |
 |
Inovio Pharmaceuticals INO |
$2.24 0.9% |
2 |
 |
Moderna MRNA |
$35.53 5.3% |
4 |
 |
Anavex Life Sciences AVXL |
$8.35 3.8% |
6 |
 |
BridgeBio Pharma BBIO |
$36.85 0.1% |
6 |
News
AXSM Alternative Data
Web Traffic
Axsome Therapeutics receives an estimated 34859 monthly visitors to axsome.com.
-
Web Traffic
34859
-
Change from Previous Month
36.5%
-
3 Month Change
46.1%
-
YoY Change
46.1%
News Mentions
Axsome Therapeutics was mentioned 6 times in the news yesterday.
-
News Mentions
6
-
Daily Change
50%
-
1 Month Change
500%
-
3 Month Change
0%
Reddit Mentions
Axsome Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
Twitter Followers
Axsome Therapeutics has 451 Twitter Followers on its main Twitter (also known as X) account, which is up by 3.2% over the last month.
-
Twitter Followers
451
-
Daily Change
0.7%
-
1 Month Change
3.2%
-
3 Month Change
21.7%
-
YoY Change
21.7%
LinkedIn Followers
28,008 are following Axsome Therapeutics on LinkedIn, up by 3% over the last month.
-
LinkedIn Followers
28008
-
Daily Change
0.1%
-
1 Month Change
3%
-
3 Month Change
7.9%
Job Postings
Axsome Therapeutics currenly has an estimated 166 open job postings, up by 104.9% over the last month.
-
Job Postings
166
-
Daily Change
0%
-
1 Month Change
104.9%
-
3 Month Change
44.3%
-
YoY Change
44.3%
LinkedIn Employees
According to LinkedIn, Axsome Therapeutics has 665 employees, up by 3.1% over the last month.
-
LinkedIn Employees
665
-
Daily Change
0%
-
1 Month Change
3.1%
-
3 Month Change
11%
-
YoY Change
11%
Business Outlook
-
Business Outlook
79
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
AXSM Financials
AXSM Key Metrics
-
Total Revenue
$104.8M
-
Net Income
-$64.6M
-
Earnings per Share
-$1.34
-
Free cash flow
-$18.5M
-
EBITDA
-$60.6M
-
EBITDA Ratio
-0.578101
-
Total Assets
$561.5M
AXSM 2-year Revenue & Income
AXSM 2-year Free Cash Flow
AXSM Technicals
AXSM SMA
AXSM RSI
FAQ
What's the current price of Axsome Therapeutics (AXSM) Stock?
The price of an Axsome Therapeutics (AXSM) share is $137.8.
What's the market cap of Axsome Therapeutics?
The current market cap of Axsome Therapeutics is 6.7B.
Should I buy or sell AXSM?
Multiple alternative data signals suggest that Axsome Therapeutics stock could offer a buying opportunity at its current level, with a reasonable expectation for positive performance in the mid term.
Is Axsome Therapeutics a good investment?
Based on an in-depth analysis that encompasses fundamentals, technical analysis, and alternative data insights, it appears to be a favorable time to consider investing in Axsome Therapeutics stock. The bullish indicators suggest that Axsome Therapeutics' growth prospects and market position may lead to a positive performance in the foreseeable future.
Is now a good time to buy Axsome Therapeutics (AXSM) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it could be a favorable time to consider buying Axsome Therapeutics stock, given the bullish outlook.
What are some stocks similar to Axsome Therapeutics (AXSM) that investors often compare it to?
Axsome Therapeutics (AXSM) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Axsome Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Axsome Therapeutics' stock price to be around $151.2 in 2026. Starting from the current price of $137.8, this represents a 9.7% change in price, indicating a bullish outlook for the stock.
How to buy Axsome Therapeutics (AXSM) Stock?
Axsome Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Axsome Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.